Advertisement
News
Advertisement

Biomet's preemption bid fails, company proceeds to trial over metal hips

Wed, 08/28/2013 - 12:29pm
Mass Device

Biomet fails to convince an Indiana federal judge that federal preemption laws protect the company against personal injury lawsuits over its metal-on-metal M2A hip.

Biomet's preemption bid fails, company faces multi-district lawsuit

Biomet will go to bat over its M2A-magnum metal-on-metal hip implants after failing to convince an Indiana federal judge that a personal injury lawsuit was preempted by FDA rules.

The plaintiff, Leslie Caccia, sued Biomet for a supposedly defective metal-on-metal hip implant in what is now part of a larger multi-district litigation. Biomet argued that the case qualifies for preemption, a controversial rule that protects manufacturers from tort claims surrounding FDA-cleared products.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading